Merck Tbk Valuation
| MERK Stock | IDR 3,410 60.00 1.73% |
At this time, the firm appears to be overvalued. Merck Tbk secures a last-minute Real Value of 2912.7 per share. The latest price of the firm is 3410.0. Our model forecasts the value of Merck Tbk from analyzing the firm fundamentals such as Profit Margin of 0.14 %, current valuation of 2.02 T, and Return On Equity of 0.23 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Merck Tbk's price fluctuation is very steady at this time. Calculation of the real value of Merck Tbk is based on 3 months time horizon. Increasing Merck Tbk's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Merck Tbk's intrinsic value may or may not be the same as its current market price of 3,410, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3410.0 | Real 2912.7 | Hype 3410.0 | Naive 3372.81 |
The intrinsic value of Merck Tbk's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Merck Tbk's stock price.
Estimating the potential upside or downside of Merck Tbk helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck Tbk more accurately as focusing exclusively on Merck Tbk's fundamentals will not take into account other important factors: Merck Tbk Total Value Analysis
Merck Tbk is now forecasted to have takeover price of 2.02 T with market capitalization of 2.19 T, debt of 13.12 B, and cash on hands of 164.7 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Merck Tbk fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.02 T | 2.19 T | 13.12 B | 164.7 B |
Merck Tbk Investor Information
About 87.0% of the company outstanding shares are owned by corporate insiders. The book value of Merck Tbk was now reported as 1621.14. The company recorded earning per share (EPS) of 365.0. Merck Tbk last dividend was issued on the 7th of June 2022. The entity had 20:1 split on the 21st of December 2015. Merck Tbk is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Merck Tbk Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Merck Tbk has an asset utilization ratio of 103.72 percent. This suggests that the Company is making 1.04 for each dollar of assets. An increasing asset utilization means that Merck Tbk is more efficient with each dollar of assets it utilizes for everyday operations.Merck Tbk Ownership Allocation
Merck Tbk maintains a total of 448 Million outstanding shares. Merck Tbk secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 86.65 % of Merck Tbk outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Merck Tbk Profitability Analysis
The company reported the revenue of 1.06 T. Net Income was 131.66 B with profit before overhead, payroll, taxes, and interest of 398.68 B.About Merck Tbk Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Merck Tbk. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Merck Tbk based exclusively on its fundamental and basic technical indicators. By analyzing Merck Tbk's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Merck Tbk's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merck Tbk. We calculate exposure to Merck Tbk's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck Tbk's related companies.PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. Merck Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 405 people.
8 Steps to conduct Merck Tbk's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Merck Tbk's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Merck Tbk's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Merck Tbk's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Merck Tbk's revenue streams: Identify Merck Tbk's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Merck Tbk's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Merck Tbk's growth potential: Evaluate Merck Tbk's management, business model, and growth potential.
- Determine Merck Tbk's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Merck Tbk's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.